Douglas Voet
Impact in
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 24
- Cancer-related molecular mechanisms research 4
-
- Genetic factors in colorectal cancer 12
- Journals
- Nature (13 papers)Nature Communications (11 papers)Nature Genetics (9 papers)Cell (4 papers)Science (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Douglas Voet
44 papers receiving 41.4k citations
Douglas Voet's Hit Papers
Peers
Comparison fields: 5 of 173
- Cancer Research 14.0k
- Oncology 12.0k
- Molecular Biology 21.8k
- Pulmonary and Respiratory Medicine 7.7k
- Reproductive Medicine 1.9k
Countries citing papers authored by Douglas Voet
This map shows the geographic impact of Douglas Voet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Voet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Voet more than expected).
Fields of papers citing papers by Douglas Voet
This network shows the impact of papers produced by Douglas Voet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Voet. The network helps show where Douglas Voet may publish in the future.
No co-authors to show.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Integrated genomic analyses of ovarian carcinoma Hit paper breakdown → | 2011 | 6345 |
| 2 | Comprehensive molecular profiling of lung adenocarcinoma Hit paper breakdown → | 2014 | 4550 |
| 3 | Mutational heterogeneity in cancer and the search for new cancer-associated genes Hit paper breakdown → | 2013 | 4266 |
| 4 | Comprehensive genomic characterization of squamous cell lung cancers Hit paper breakdown → | 2012 | 3290 |
| 5 | Genomic Classification of Cutaneous Melanoma Hit paper breakdown → | 2015 | 2509 |
| 6 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 7 | A Landscape of Driver Mutations in Melanoma Hit paper breakdown → | 2012 | 2138 |
| 8 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 9 | The Mutational Landscape of Head and Neck Squamous Cell Carcinoma Hit paper breakdown → | 2011 | 2103 |
| 10 | Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma Hit paper breakdown → | 2017 | 1970 |
| 11 | Initial genome sequencing and analysis of multiple myeloma Hit paper breakdown → | 2011 | 1207 |
| 12 | The genomic complexity of primary human prostate cancer Hit paper breakdown → | 2011 | 1017 |
| 13 | Punctuated Evolution of Prostate Cancer Genomes Hit paper breakdown → | 2013 | 1004 |
| 14 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 15 | Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity Hit paper breakdown → | 2013 | 621 |
| 16 | Melanoma genome sequencing reveals frequent PREX2 mutations Hit paper breakdown → | 2012 | 604 |
| 17 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 550 |
| 18 | Integrative Molecular Characterization of Malignant Pleural Mesothelioma Hit paper breakdown → | 2018 | 480 |
| 19 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 476 |
| 20 | Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine Hit paper breakdown → | 2014 | 452 |
About Douglas Voet
Douglas Voet is a scholar working on Cancer Research, Pathology and Forensic Medicine, Molecular Biology, Oncology and Genetics, having authored 44 papers that have together received 42.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (24 papers), Genetic factors in colorectal cancer (12 papers), RNA modifications and cancer (6 papers), RNA Research and Splicing (5 papers), Genomics and Phylogenetic Studies (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer-related gene regulation (4 papers) and Genomics and Rare Diseases (4 papers). The work is most often cited by research in Cancer Research (14.0k citations), Oncology (12.0k citations), Molecular Biology (21.8k citations), Pulmonary and Respiratory Medicine (7.7k citations) and Reproductive Medicine (1.9k citations). Douglas Voet has collaborated with scholars based in United States, Canada and United Kingdom. Their work appears in journals such as Nature, Nature Communications, Nature Genetics, Cell and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.